US Pharma MarketingThe post Edwards Lifesciences served $10m penalty over JC Medical acquisition violations appeared first on Medical Device Network.
Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
The FTC secured the penalty after a court ruled that Edwards failed to comply with antitrust law requirements when it acquired JC Medical in 2024. The FTC secured the penalty after a court ruled that Edwards failed to comply with antitrust law requirements when it acquired JC Medical in 2024. Edwards was deemed to have intentionally bypassed US antitrust law to mitigate scrutiny over its acquisition of JC Medical. Credit: lucasImages / Shutterstock.com Edwards Lifesciences has been hit with a $10m penalty to settle a court ruling that determined the company violated antitrust law in its acquisition of JC Medical…
The FTC secured the penalty after a court ruled that Edwards failed to comply with antitrust law requirements when it acquired JC Medical in 2024.
Source: Medical Device Network